Navigation Links
Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
Date:8/3/2009

erweight patients with type 2 diabetes. Results from BLOOM-DM will be submitted as a supplement to the lorcaserin NDA filing.
  • Announced a late-breaking poster presentation of positive results from BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management), the first of two pivotal trials evaluating the safety and efficacy of lorcaserin for weight management, at the 69th Scientific Sessions of the American Diabetes Association. Lorcaserin patients achieved highly significant categorical and absolute weight loss in Year 1, and continued treatment with lorcaserin in Year 2 helped significantly more patients maintain their weight loss as compared to those on placebo. 66.4% of lorcaserin patients who completed one year of treatment according to the trial's protocol lost at least 5% of their weight and the average weight loss in this responder population was 26 pounds. Treatment with lorcaserin also resulted in highly significant improvements as compared to placebo in multiple secondary endpoints associated with cardiovascular risk. Lorcaserin was very well tolerated, did not result in increased risk of depression and was not associated with development of cardiac valvular insufficiency.
  • Ortho-McNeil-Janssen completed a Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of a single ascending dose of APD597 in healthy volunteers. Ortho-McNeil-Janssen has initiated another clinical trial evaluating multiple ascending doses of APD597.
  • Completed a public offering of 12.5 million shares of common stock, resulting in net proceeds to Arena of approximately $49.7 million.
  • Received net proceeds of $95.6 million from a $100.0 million secured loan provided by Deerfield Management. The outstanding principal accrues interest until maturity in June 2013 at a rate of 7.75% per annum. In connection with the loan, Arena issued Deerfield warrants for 28 million
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine news :

    1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
    2. Arena Pharmaceuticals Announces Public Offering of Common Stock
    3. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
    4. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
    5. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
    6. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
    7. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
    8. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
    9. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
    10. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
    11. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/5/2015)... 2015 On March 2, 2015, NBC ... on the Rise, Plastic Surgeons Say,” that comments on ... for Aesthetic Plastic Surgery and the American ... a year-over-year doubling of surgical butt augmentations performed in ... the article, this increase can be attributed to the ...
    (Date:3/5/2015)... PA (PRWEB) March 05, 2015 ... leader in healthcare communications and education, announced today ... (AMP), the nation’s only medical conference designed ... limb ischemia and lower limb amputation due to ... growing family of innovative, evidence-based publications and CME ...
    (Date:3/5/2015)... 2015 Supply & Demand Chain Executive ... “Pros to Know” in the supply chain industry, and ... MEBC’s leadership team were included on this year’s list! ... this award due to their hard work, their commitment ... meeting and resolving client needs and challenges. ...
    (Date:3/5/2015)... 05, 2015 Leading nutritional supplement provider ... Arnold Sports Festival and Arnold Fitness EXPO ... Nutrition will host a display booth featuring free samples ... and its highly-popular, class-leading fat burner Synedrex. The company ... recipes that utilize its top-of-the-line supplements and miniature action ...
    (Date:3/5/2015)... OAK BROOK, Ill. (PRWEB) March 05, 2015 ... It may be even tougher to get them to brush ... more than 1,300 parents released today by Delta Dental(1) in ... half of parents (45 percent) say getting kids to brush ... get their kids to do. That’s slightly higher than getting ...
    Breaking Medicine News(10 mins):Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 3
    ... less hyperactivity, depression and anxiety, research suggests , MONDAY, June ... beneficial to caregivers who may need a break. For children ... day may help reduce hyperactivity, anxiety and depression, new study ... as either napping (77 percent) or non-napping (23 percent), researchers ...
    ... children are more likely to get diagnosed with diabetes than ... Clinical Evaluative Sciences (ICES) has found a 3 per cent ... children from 1994 to 2004. Childhood diabetes is ... children with diabetes have Type 1, where their pancreas does ...
    ... , CINCINNATI, June 8 Kendle (Nasdaq: KNDL ... the Company will participate in the upcoming Jefferies 3rd Annual ... Securities 19th Annual Mid-Year Equity Conference on June 24. , ... ) , , President Simon Higginbotham will participate ...
    ... Face Workplace Challenges , , WASHINGTON, June 8 ... solve long-term challenges for many employers, as the traditional labor pool ... being released today at AARP,s Diversity and Aging conference in Chicago. ... ) , , That is a key finding of ...
    ... and women say that stress levels have ... long term financial stability, a recent study reports(1). "Times are tough ... anxious and worried about, and people don,t know where to turn ... Stress and Anxiety. As the financial markets suffered steep declines ...
    ... direction of Melinda Sothern, PhD, Professor and Director of ... Orleans School of Public Health, showing early signs of ... old will be presented at the American Diabetes Association ... Sothern,s group is the first to document previously unknown ...
    Cached Medicine News:Health News:Kendle to Present at Upcoming Jefferies and Wachovia Securities Conferences 2Health News:Hispanic Workers Ages 50+ May Help Employers Solve Potential Future Labor Shortages 2Health News:Hispanic Workers Ages 50+ May Help Employers Solve Potential Future Labor Shortages 3Health News:Midwest Center for Stress and Anxiety Releases New Program, The Solution to Controlling Stress and Worry 2Health News:Midwest Center for Stress and Anxiety Releases New Program, The Solution to Controlling Stress and Worry 3Health News:LSUHSC researchers first to document early signs for diabetes in kids as young as 7 2Health News:LSUHSC researchers first to document early signs for diabetes in kids as young as 7 3
    (Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... "Japan Pharma Outlook 2015: Year to Watch out ... report to their offering. The ... from April -2014 (Annexure 1) is a game ... whether generic or innovator. The most of the companies ...
    (Date:3/5/2015)... 2015 Hitachi Medical Systems ... OASIS *    at ECR 2015 - the ... set a benchmark for patient-centric care. The new features ... whilst optimizing workflow management and costs. OASIS demonstrates the ... for imaging in Neurology, Orthopaedics, Paediatrics, Oncology, Vascular and ...
    (Date:3/5/2015)... VIENNA , March 5, 2015 ... Aloka Medical Ltd., Tokyo, Japan , ... extraordinary compact, portable Ultrasound Bone Densitometry System at the ... to see and test EggQus at the Hitachi Medical ... http://photos.prnewswire.com/prnh/20150305/732754-a ) ,      (Photo: ...
    Breaking Medicine Technology:Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3Hitachi Aloka Medical, Ltd. Introduces EggQus AOS 100E - a Compact and Lightweight Ultrasound Bone Densitometry System 2Hitachi Aloka Medical, Ltd. Introduces EggQus AOS 100E - a Compact and Lightweight Ultrasound Bone Densitometry System 3
    ... Generex Biotechnology Corporation ( www.generex.com ) (OTC Bulletin ... peer-reviewed scientific journal Diabetes, Obesity and Metabolism ... Oral-lyn™, the Company,s proprietary buccal insulin spray product. ... subjects with impaired glucose tolerance: the prevoral study , ...
    ... Bionovo, Inc. (Nasdaq: BNVI ), a pharmaceutical company ... women,s health and cancer, today announced that it had received ... Clinical Guidance meeting that took place on November 8, 2010. ... overall clinical development plan. "We had a ...
    Cached Medicine Technology:Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 2Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 3Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 4Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 5Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 2Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 3Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 4
    ... The Bledsoe Revolution Knee ... speed fitting under post-op ... the surgeon or authorized ... post-op fitting and application ...
    The Bledsoe Post-Op Knee Brace is designed to provide maximum protection without sacrificing comfort and quick, easy application....
    ... Room Knee Brace frees the ... the time-consuming post-op fitting and ... more complex brace designs. The ... provides the same benefits as ...
    ... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
    Medicine Products: